Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Prepaid Assets (2021 - 2025)

Historic Prepaid Assets for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $660280.0.

  • InMed Pharmaceuticals' Prepaid Assets rose 253.02% to $660280.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $660280.0, marking a year-over-year increase of 253.02%. This contributed to the annual value of $321747.0 for FY2025, which is 3265.35% down from last year.
  • As of Q4 2025, InMed Pharmaceuticals' Prepaid Assets stood at $660280.0, which was up 253.02% from $191755.0 recorded in Q3 2025.
  • InMed Pharmaceuticals' 5-year Prepaid Assets high stood at $1.3 million for Q1 2022, and its period low was $140512.0 during Q4 2021.
  • For the 5-year period, InMed Pharmaceuticals' Prepaid Assets averaged around $569300.5, with its median value being $502952.5 (2023).
  • In the last 5 years, InMed Pharmaceuticals' Prepaid Assets soared by 48851.27% in 2022 and then plummeted by 5014.44% in 2025.
  • Quarter analysis of 5 years shows InMed Pharmaceuticals' Prepaid Assets stood at $140512.0 in 2021, then soared by 488.51% to $826931.0 in 2022, then soared by 34.59% to $1.1 million in 2023, then plummeted by 42.14% to $643986.0 in 2024, then increased by 2.53% to $660280.0 in 2025.
  • Its Prepaid Assets stands at $660280.0 for Q4 2025, versus $191755.0 for Q3 2025 and $321747.0 for Q2 2025.